Toll Free: 1-888-928-9744

Neurovascular Stents - Medical Devices Pipeline Assessment, 2016

Published: Jun 1, 2016 | Pages: 43 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Neurovascular Stents - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Neurovascular Stents - Medical Devices Pipeline Assessment, 2016" provides an overview of Neurovascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Neurovascular Stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Neurovascular Stents under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Neurovascular Stents and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons To Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Neurovascular Stents under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
1 Table of Contents 2 1.1 List of Tables 4 1.2 List of Figures 5 2 Introduction 6 2.1 Neurovascular Stents Overview 6 3 Products under Development 7 3.1 Neurovascular Stents - Pipeline Products by Stage of Development 7 3.2 Neurovascular Stents - Pipeline Products by Territory 8 3.3 Neurovascular Stents - Pipeline Products by Regulatory Path 9 3.4 Neurovascular Stents - Pipeline Products by Estimated Approval Date 10 3.5 Neurovascular Stents - Ongoing Clinical Trials 11 4 Neurovascular Stents - Pipeline Products under Development by Companies 12 4.1 Neurovascular Stents Companies - Pipeline Products by Stage of Development 12 4.2 Neurovascular Stents - Pipeline Products by Stage of Development 13 5 Neurovascular Stents Companies and Product Overview 14 5.1 Aneuclose LLC Company Overview 14 5.1.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 14 5.2 Apeliotus Technologies Company Overview 16 5.2.1 Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 16 5.3 DePuy Synthes, Inc. Company Overview 17 5.3.1 DePuy Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17 5.4 Gaudi Vascular, Inc. Company Overview 20 5.4.1 Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20 5.5 InspireMD, Inc. Company Overview 21 5.5.1 InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21 5.6 MicroVention, Inc. Company Overview 23 5.6.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23 5.7 NeuroSigma, Inc. Company Overview 27 5.7.1 NeuroSigma, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27 5.8 NSVascular, Inc. Company Overview 29 5.8.1 NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29 5.9 Oxford Endovascular Limited Company Overview 31 5.9.1 Oxford Endovascular Limited Pipeline Products & Ongoing Clinical Trials Overview 31 5.10 Palmaz Scientific, Inc. Company Overview 32 5.10.1 Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32 5.11 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 33 5.11.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 33 6 Neurovascular Stents- Recent Developments 34 6.1 May 10, 2016: InspireMD Reports Financial Results for the First Quarter Ended March 31, 2016 34 6.2 Apr 27, 2016: Bard Announces First Quarter Results 35 6.3 Feb 16, 2016: Codman Neuro Announces Launch Of Codman Enterprise 2 35 6.4 Jan 29, 2016: Bard Announces Fourth Quarter Results 36 6.5 Oct 22, 2015: Bard Announces Third Quarter Results 37 6.6 Jul 23, 2015: Bard Announces Second Quarter Results 37 6.7 Jul 21, 2015: FDA Issues Warning Letter To C. R. Bard 38 6.8 Jul 17, 2015: EndoShape Raises USD1.2 Million in Venture Financing 38 6.9 Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean 38 6.10 Jul 03, 2015: MicroPort NeuroTech Attends CSA&TISC to Promote APOLLO 39 7 Appendix 40 7.1 Methodology 40 7.2 About GlobalData 42 7.3 Contact Us 43 7.4 Disclaimer 43
List of Tables
Table 1: Neurovascular Stents - Pipeline Products by Stage of Development 7 Table 2: Neurovascular Stents - Pipeline Products by Territory 8 Table 3: Neurovascular Stents - Pipeline Products by Regulatory Path 9 Table 4: Neurovascular Stents - Pipeline Products by Estimated Approval Date 10 Table 5: Neurovascular Stents - Ongoing Clinical Trials 11 Table 6: Neurovascular Stents Companies - Pipeline Products by Stage of Development 12 Table 7: Neurovascular Stents - Pipeline Products by Stage of Development 13 Table 8: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 14 Table 9: Aneurysm Occlusion Saddle - Product Status 15 Table 10: Aneurysm Occlusion Saddle - Product Description 15 Table 11: Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 16 Table 12: Polymer Stent for Cerebral Aneurysms - Product Status 16 Table 13: Polymer Stent for Cerebral Aneurysms - Product Description 16 Table 14: DePuy Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17 Table 15: Covered Stent - Product Status 17 Table 16: Covered Stent - Product Description 17 Table 17: Next Generation Balloon Expandable Stent - Product Status 18 Table 18: Next Generation Balloon Expandable Stent - Product Description 18 Table 19: Self-Expanding Stent - Product Status 19 Table 20: Self-Expanding Stent - Product Description 19 Table 21: Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20 Table 22: Intracranial Stent - Product Status 20 Table 23: Intracranial Stent - Product Description 20 Table 24: InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21 Table 25: NVGuard Neurovascular - Product Status 22 Table 26: NVGuard Neurovascular - Product Description 22 Table 27: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23 Table 28: FRED Flow-Diverting Stent - Product Status 24 Table 29: FRED Flow-Diverting Stent - Product Description 24 Table 30: MicroVention, Inc. - Ongoing Clinical Trials Overview 25 Table 31: FRED Flow-Diverting Stent - Pivotal Study of the MicroVention Flow Re-Direction Endoluminal Device (FRED) Stent System in the Treatment of Intracranial Aneurysms 26 Table 32: NeuroSigma, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27 Table 33: Thin Film Nitinol Flow Diverting Stent - Product Status 28 Table 34: Thin Film Nitinol Flow Diverting Stent - Product Description 28 Table 35: NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29 Table 36: Flow-Diverting TFN Stent - Product Status 30 Table 37: Flow-Diverting TFN Stent - Product Description 30 Table 38: Oxford Endovascular Limited Pipeline Products & Ongoing Clinical Trials Overview 31 Table 39: Oxiflow - Product Status 31 Table 40: Oxiflow - Product Description 31 Table 41: Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32 Table 42: Micro Neuro-Stent - Product Status 32 Table 43: Micro Neuro-Stent - Product Description 32 Table 44: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 33 Table 45: Flow Diversion Intracranial Stent - Product Status 33 Table 46: Flow Diversion Intracranial Stent - Product Description 33 Table 47: Glossary 41


List of Figures
Figure 1: Neurovascular Stents - Pipeline Products by Stage of Development 7 Figure 2: Neurovascular Stents - Pipeline Products by Territory 8 Figure 3: Neurovascular Stents - Pipeline Products by Regulatory Path 9 Figure 4: Neurovascular Stents - Pipeline Products by Estimated Approval Date 10 Figure 5: Neurovascular Stents - Ongoing Clinical Trials 11

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global engineering service outsourcing market size is likely to be valued at USD 415.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Rapid alignment of OEMs accompanied by increasing focus on efficient performance and reliab

Read More...

Global adhesives & sealants market size is expected to reach USD 43.19 billion by 2020, as per a new research report by Radiant Insights, Inc. Strong demand from packaging, construction and automotive industries is expected drive adhesives and sealan

Read More...

Global thermoplastic polyurethane (TPU) films market size is likely to be valued at USD 724.6 million by 2020; as per a new research report by Radiant Insights, Inc. Increase in lightweight plastics demand in order to achieve vehicle fuel efficiency

Read More...

Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to driv

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify